No Data
No Data
Imricor Medical Systems' VISABL-AFL Trial Receives Final Clearance From Swissmedic
Imricor Medical Systems (ASX:IMR) received approval from Swissmedic for the VISABL-AFL clinical trial to commence at the Lausanne University Hospital in Switzerland, according to a Thursday filing wit
Imricor Medical Systems Announces Release of Certain Stocks From Voluntary Escrow
Imricor Medical Systems (ASX:IMR) said certain stocks issued to directors will be released from voluntary escrow. These include 74,574 securities to be released from escrow on May 9 and 132,023 securi
Imricor Medical Systems Secures First Catheter Order From Croatia's Dubrava University Hospital
Imricor Medical Systems (ASX:IMR) received its first order of catheters and other consumable devices from Dubrava University Hospital in Zagreb, Croatia, according to a Thursday filing with the Austra
Imricor Medical Systems Gains Approval for Clinical Trial at Cardiovascular Institute of South Paris; Shares Up 7%
Imricor Medical Systems (ASX:IMR) secured the final approval from the French National Agency for Medicines and Health Products for the VISABL-AFL clinical trial to commence at the Cardiovascular Insti
Amsterdam University Medical Center Resumes Atrial Flutter Procedures With Imricor's NorthStar Mapping System
Imricor Medical Systems (ASX:IMR) said that the Amsterdam University Medical Center physicians restarted routine atrial flutter procedures using the company's NorthStar 3D mapping technology, accordin
Imricor Medical Systems Completes AU$6.4 Million Shortfall Share Issue
Imricor Medical Systems (ASX:IMR) has completed its issue of about AU$6.4 million in shortfall securities as part of its pro-rata non renounceable entitlement offer at AU$0.45 per CHESS depositary int
No Data